Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 20, 2024 | (FY)Mar 20, 2023 | (FY)Mar 20, 2022 | (FY)Mar 20, 2021 | (FY)Mar 20, 2020 | (FY)Mar 20, 2019 | (FY)Mar 20, 2018 | (FY)Mar 20, 2017 | (FY)Mar 20, 2016 | (FY)Feb 20, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 99.29%-5.25M | -135.36%-734.2M | -129.99%-311.95M | -123.65%-135.64M | 274.05%573.51M | -117.03%-329.51M | -126.32%-151.82M | 133.64%576.91M | -64.11%246.92M | 201.19%687.9M |
Net profit before non-cash adjustment | 52.02%68.57M | -89.90%45.1M | 246.92%446.72M | 122.75%128.77M | -225.27%-565.99M | -393.45%-174M | 103.72%59.3M | -264.70%-1.59B | 47.69%-436.58M | -727.60%-834.64M |
Total adjustment of non-cash items | 66.16%86.05M | 115.81%51.79M | -1,351.67%-327.47M | -108.86%-22.56M | 165.67%254.64M | 287.26%95.85M | -96.69%24.75M | 253.56%746.91M | -41.50%211.26M | 368.32%361.11M |
-Depreciation and amortization | 54.53%48.19M | 167.07%31.19M | 431.26%11.68M | -85.96%2.2M | 119.41%15.65M | 262.13%7.13M | -96.77%1.97M | -46.36%61.02M | -15.53%113.76M | 46.90%134.68M |
-Reversal of impairment losses recognized in profit and loss | --34.09M | --0 | ---- | ---- | 1,136.41%139.15M | 26.49%11.25M | -98.51%8.9M | 857.95%595.72M | -34.15%62.19M | 994.26%94.44M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 71.35%-10.9M | 83.86%-38.03M |
-Disposal profit | 4,759.86%27.36M | 100.25%563K | ---222.11M | ---- | -59.38%6.27M | 151.56%15.44M | -210.96%-29.94M | --26.98M | ---- | -163.11%-18.64M |
-Other non-cash items | -217.74%-23.59M | 117.12%20.04M | -372.75%-117.04M | -126.46%-24.76M | 50.86%93.57M | 41.54%62.02M | -30.65%43.82M | 36.74%63.19M | -75.51%46.21M | 754.72%188.67M |
Changes in working capital | 80.76%-159.87M | -92.74%-831.09M | -78.30%-431.2M | -127.33%-241.84M | 452.03%884.85M | -6.57%-251.36M | -116.58%-235.87M | 201.16%1.42B | -59.34%472.24M | 271.25%1.16B |
-Change in receivables | -149.72%-189.15M | -155.11%-75.74M | 119.39%137.45M | -842.90%-708.82M | 164.57%95.41M | 209.95%36.06M | -183.98%-32.8M | 183.84%39.05M | 15.14%13.76M | -89.46%11.95M |
-Change in inventory | 66.21%-192.37M | -40.66%-569.37M | -629.83%-404.77M | -110.19%-55.46M | 468.65%544.41M | -720.87%-147.68M | -98.20%23.79M | 263.33%1.32B | -67.77%363.24M | 232.72%1.13B |
-Change in prepaid assets | 115.49%2.79M | 45.85%-17.99M | -374.96%-33.21M | -105.03%-6.99M | 3,765.03%138.91M | 385.02%3.59M | 48.50%741K | -85.09%499K | -19.12%3.35M | 289.94%4.14M |
-Change in payables | 208.37%150.48M | -378.37%-138.86M | -105.37%-29.03M | 387.27%540.25M | 181.46%110.87M | 31.25%-136.11M | -323.00%-197.98M | -50.14%88.78M | 250.13%178.04M | -605.99%-118.59M |
-Change in accrued expense | ---- | ---- | ---- | 40.69%-1.39M | 17.94%-2.35M | -174.75%-2.86M | 190.75%3.83M | 95.10%-4.22M | -162.92%-86.07M | 288.19%136.79M |
-Provision for loans, leases and other losses | 1.76%-9.62M | -173.16%-9.79M | 241.86%13.38M | -292.51%-9.43M | 44.97%-2.4M | 86.94%-4.37M | -229.70%-33.45M | --25.79M | ---- | ---- |
-Changes in other current assets | 503.20%78M | 83.18%-19.35M | ---115.01M | ---- | ---- | ---- | ---- | -67,695.71%-47.46M | -600.00%-70K | -99.99%14K |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 6.99%-44.32M | -14.27%-47.65M | -18.40%-41.7M | -6.93%-35.22M | 12.34%-32.94M | 31.28%-37.57M | -0.20%-54.68M | 23.08%-54.57M | 10.07%-70.95M | -45.26%-78.89M |
Interest received (cash flow from operating activities) | 11.93%2.82M | 25.65%2.52M | 1.47%2.01M | -4.26%1.98M | 11.73%2.07M | 4.76%1.85M | -9.39%1.77M | -18.11%1.95M | 16.67%2.38M | 3.19%2.04M |
Tax refund paid | 75.34%-15.65M | -172.10%-63.45M | -90.45%-23.32M | 5.68%-12.24M | 13.68%-12.98M | 19.26%-15.04M | 26.18%-18.62M | -1.40%-25.23M | -4.49%-24.88M | 12.63%-23.81M |
Other operating cash inflow (outflow) | 7,080,300.00%70.8M | -1K | 0 | -2.12M | 0 | 0 | -200.00%-1K | 200.00%1K | -1K | 0 |
Operating cash flow | 101.00%8.42M | -124.76%-842.77M | -104.63%-374.96M | -134.60%-183.24M | 239.28%529.66M | -70.25%-380.27M | -144.76%-223.36M | 225.17%499.06M | -73.87%153.48M | 188.71%587.24M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 20.65%-53.89M | -125.96%-67.92M | 9,368.86%261.66M | 95.42%-2.82M | -23.48%-61.7M | -124.03%-49.97M | 504.33%207.92M | -87.68%-51.42M | 79.00%-27.4M | 40.30%-130.5M |
Net intangibles purchase and sale | -113.23%-13.3M | 68.66%-6.24M | -350.07%-19.89M | 34.92%-4.42M | 53.43%-6.79M | -736.18%-14.58M | 51.37%-1.74M | -131.35%-3.59M | 93.73%-1.55M | -4,986.63%-24.72M |
Net business purchase and sale | ---- | ---- | ---- | ---15M | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | --23.11M | --0 | 117.86%4M | ---22.4M | ---- | -99.32%1M | 500.65%146M | --24.31M | ---- | --28.87M |
Net changes in other investments | 57.99%-10.46M | 63.70%-24.89M | -1,098.01%-68.55M | 140.51%6.87M | -188.91%-16.96M | -83.81%19.07M | -10.67%117.81M | 175.79%131.88M | 224.72%47.82M | -84.68%14.73M |
Investing cash flow | 44.94%-54.53M | -155.88%-99.04M | 569.17%177.21M | 55.80%-37.77M | -92.09%-85.45M | -109.46%-44.48M | 364.50%469.98M | 436.19%101.18M | 116.90%18.87M | 9.05%-111.62M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -109.73%-95.72M | 163.03%984.22M | 1,392.44%374.19M | 196.53%25.07M | 83.91%-25.97M | 69.05%-161.43M | -351.18%-521.6M | 83.36%-115.61M | -737.20%-694.9M | -88.84%109.06M |
Net common stock issuance | --0 | -91.10%1.62M | -82.06%18.25M | 136.83%101.71M | 204,614.29%42.95M | -100.01%-21K | 145,841.01%202.58M | 59.83%-139K | -86.02%-346K | -60.34%-186K |
Increase or decrease of lease financing | -120.25%-5.51M | -47.00%27.19M | 2,952.29%51.31M | 109.68%1.68M | 29.46%-17.37M | 32.06%-24.62M | -160.11%-36.24M | 77.93%-13.93M | 9.58%-63.13M | -11.81%-69.82M |
Cash dividends paid | 79.84%-20.29M | ---100.66M | ---- | ---- | ---- | ---- | 42.04%-142K | -178.41%-245K | 99.39%-88K | -1.72%-14.41M |
Net other fund-raising expenses | 91.02%-9.15M | -7,451.00%-101.86M | -127.72%-1.35M | 162,300.00%4.87M | -200.00%-3K | -100.11%-1K | 102.96%879K | 29.97%-29.69M | -84.04%-42.39M | -383.68%-23.03M |
Financing cash flow | -116.12%-130.67M | 83.21%810.51M | 231.79%442.39M | 33,600.75%133.33M | 99.79%-398K | 47.51%-186.07M | -122.11%-354.52M | 80.07%-159.61M | -49,811.48%-800.85M | -99.82%1.61M |
Net cash flow | ||||||||||
Beginning cash position | -18.12%593.2M | 50.99%724.47M | -15.44%479.82M | 358.84%567.46M | -83.16%123.67M | -12.81%734.52M | 109.65%842.39M | -61.00%401.8M | 86.28%1.03B | 25.01%553.11M |
Current changes in cash | -34.65%-176.79M | -153.67%-131.3M | 379.03%244.65M | -119.76%-87.68M | 172.66%443.81M | -466.12%-610.83M | -124.49%-107.9M | 170.11%440.63M | -231.70%-628.51M | 331.44%477.23M |
Effect of exchange rate changes | 110.00%63K | 400.00%30K | -81.82%6K | 243.48%33K | -43.75%-23K | -161.54%-16K | 178.79%26K | 8.33%-33K | ---36K | --0 |
Cash adjustments other than cash changes | ---- | ---- | 0.00%1K | 200.00%1K | 66.67%-1K | ---3K | ---- | ---- | ---- | ---- |
End cash Position | -29.79%416.48M | -18.12%593.2M | 50.99%724.47M | -15.44%479.82M | 358.84%567.46M | -83.16%123.67M | -12.81%734.52M | 109.65%842.39M | -61.00%401.8M | 86.28%1.03B |
Free cash flow | 93.59%-58.77M | -93.59%-916.92M | -148.66%-473.64M | -141.30%-190.48M | 203.67%461.16M | -71.68%-444.82M | -158.35%-259.1M | 256.59%444.05M | -71.18%124.53M | 149.04%432.02M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |